Skip to main content
Top
Published in: Immunologic Research 6/2022

25-07-2022 | Primary Immunodeficiency | Original Article

Somatic hypermutation defects in two adult hyper immunoglobulin M patients

Authors: Hülya Yilmaz, Sinem Fırtına, Merve Sarıtaş, Müge Sayitoğlu, Muhlis Cem Ar

Published in: Immunologic Research | Issue 6/2022

Login to get access

Abstract

Hyper immunoglobulin M (HIGM) syndrome is a rare disorder of the immune system with impaired antibody functions. The clinical picture of the patients varies according to the underlying genetic variation. In this study, we identified two novel variants in AID and UNG genes, which are associated with autosomal recessive type HIGM, by targeted next-generation sequencing (NGS) panel. A biallelic 11 base pair deletion (c.278_288delATGTGGCCGAC) in the coding sequence of activation-induced cytidine deaminase (AID) gene was identified in a 36-year-old patient. Biallelic two base pair insertion in exon 7 of uracil nucleoside glycosylase (UNG) gene (c.924_925insGG) was identified in a 40-year-old patient. Both variants were confirmed by Sanger sequencing. HIGM, like many of the other primary immunodeficiencies, is a rare and difficult-to-diagnose entity with heterogeneous clinical phenotypes. It should be suspected in patients with a history of early-onset recurrent respiratory infections, enlarged lymph nodes, and autoimmune disorders. There might be a delay in diagnosis until adulthood especially in subtle cases or if HIGM is not included in the differential diagnosis due lacking of awareness. In this regard, genetic testing with NGS-based diagnostic panels provide a rapid and reasonable tool for the molecular diagnosis of patients with immunodeficiencies and hence, decrease the time to diagnose and prevent infection-related complications associated with increased morbidity and mortality.
Literature
2.
go back to reference Lougaris V, Badolato R, Ferrari S, Plebani A. Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features. Immunol Rev. 2005;203(1):48–66.CrossRefPubMed Lougaris V, Badolato R, Ferrari S, Plebani A. Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features. Immunol Rev. 2005;203(1):48–66.CrossRefPubMed
3.
go back to reference Liu X, Zhou K, Yu D, Cai X, Hua Y, Zhou H, Wang C. A delayed diagnosis of X-linked hyper IgM syndrome complicated with toxoplasmic encephalitis in a child: a case report and literature review. Medicine. 2017;96(49). Liu X, Zhou K, Yu D, Cai X, Hua Y, Zhou H, Wang C. A delayed diagnosis of X-linked hyper IgM syndrome complicated with toxoplasmic encephalitis in a child: a case report and literature review. Medicine. 2017;96(49).
4.
go back to reference Kutukculer N, Moratto D, Aydinok Y, Lougaris V, Aksoylar S, Plebani A, Notarangelo LD. Disseminated cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency. J Paediatr. 2003;142(2):194–6.CrossRef Kutukculer N, Moratto D, Aydinok Y, Lougaris V, Aksoylar S, Plebani A, Notarangelo LD. Disseminated cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency. J Paediatr. 2003;142(2):194–6.CrossRef
5.
go back to reference Mazzolari E, Lanzi G, Forino C, Lanfranchi A, Aksu G, Ozturk C, Kutukculer N. First report of successful stem cell transplantation in a child with CD40 deficiency. Bone Marrow Transplant. 2007;40(3):279.CrossRefPubMed Mazzolari E, Lanzi G, Forino C, Lanfranchi A, Aksu G, Ozturk C, Kutukculer N. First report of successful stem cell transplantation in a child with CD40 deficiency. Bone Marrow Transplant. 2007;40(3):279.CrossRefPubMed
6.
go back to reference Lanzi G, Ferrari S, Vihinen M, Caraffi S, Kutukculer N, Schiaffonati L, Giliani S. Different molecular behavior of CD40 mutants causing hyper-IgM syndrome. Blood. 2010;116(26):5867–74.CrossRefPubMed Lanzi G, Ferrari S, Vihinen M, Caraffi S, Kutukculer N, Schiaffonati L, Giliani S. Different molecular behavior of CD40 mutants causing hyper-IgM syndrome. Blood. 2010;116(26):5867–74.CrossRefPubMed
7.
go back to reference Imai K, Slupphaug G, Lee WI, Revy P, Nonoyama S, Catalan N, Ochs HD. Human uracil–DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol. 2003;4(10):1023.CrossRefPubMed Imai K, Slupphaug G, Lee WI, Revy P, Nonoyama S, Catalan N, Ochs HD. Human uracil–DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol. 2003;4(10):1023.CrossRefPubMed
8.
go back to reference Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood. 2000;105(5):1881–90.CrossRef Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood. 2000;105(5):1881–90.CrossRef
9.
go back to reference Etzioni A, Ochs HD. The hyper IgM syndrome—an evolving story. Pediatr Res. 2000;56(4):519.CrossRef Etzioni A, Ochs HD. The hyper IgM syndrome—an evolving story. Pediatr Res. 2000;56(4):519.CrossRef
10.
go back to reference Imai K, Catalan N, Plebani A, Maródi L, Sanal Ö, Kumaki S, Hermine O. Hyper-IgM syndrome type 4 with a B lymphocyte–intrinsic selective deficiency in Ig class-switch recombination. J Clin Investig. 2003;112(1):136–42.CrossRefPubMedPubMedCentral Imai K, Catalan N, Plebani A, Maródi L, Sanal Ö, Kumaki S, Hermine O. Hyper-IgM syndrome type 4 with a B lymphocyte–intrinsic selective deficiency in Ig class-switch recombination. J Clin Investig. 2003;112(1):136–42.CrossRefPubMedPubMedCentral
11.
go back to reference Pecori R, Di Giorgio S, Lorenzo JP, Papavasiliou FN. Functions and consequences of AID/APOBEC-mediated DNA and RNA deamination. Nature Reviews Genetics. 2022;1–14. Pecori R, Di Giorgio S, Lorenzo JP, Papavasiliou FN. Functions and consequences of AID/APOBEC-mediated DNA and RNA deamination. Nature Reviews Genetics. 2022;1–14.
12.
go back to reference Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, Tezcan I. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell. 2000;102(5):565–75.CrossRefPubMed Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, Tezcan I. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell. 2000;102(5):565–75.CrossRefPubMed
13.
go back to reference Trotta L, Hautala T, Hämäläinen S, Syrjänen J, Viskari H, Almusa H, Seppänen M. Enrichment of rare variants in population isolates: single AICDA mutation responsible for hyper-IgM syndrome type 2 in Finland. Eur J Human Genet 2016;1473. Trotta L, Hautala T, Hämäläinen S, Syrjänen J, Viskari H, Almusa H, Seppänen M. Enrichment of rare variants in population isolates: single AICDA mutation responsible for hyper-IgM syndrome type 2 in Finland. Eur J Human Genet 2016;1473.
14.
go back to reference Erdős M, Garami M, Rákóczi É, Zalatnai A, Steinbach D, Baumann U, Maródi L. Neuroendocrine carcinoma associated with X-linked hyper-immunoglobulin M syndrome: report of four cases and review of the literature. Clin Immunol. 2008;129(3):455–61.CrossRefPubMed Erdős M, Garami M, Rákóczi É, Zalatnai A, Steinbach D, Baumann U, Maródi L. Neuroendocrine carcinoma associated with X-linked hyper-immunoglobulin M syndrome: report of four cases and review of the literature. Clin Immunol. 2008;129(3):455–61.CrossRefPubMed
15.
go back to reference Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, Conley ME. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine. 2003;82(6):373–84.CrossRefPubMed Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, Conley ME. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine. 2003;82(6):373–84.CrossRefPubMed
16.
go back to reference Hervé M, Isnardi I, Ng YS, Bussel JB, Ochs HD, Cunningham-Rundles C, Meffre E, et al. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance. J Exp Med. 2007;204(7):1583–93.CrossRefPubMedPubMedCentral Hervé M, Isnardi I, Ng YS, Bussel JB, Ochs HD, Cunningham-Rundles C, Meffre E, et al. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance. J Exp Med. 2007;204(7):1583–93.CrossRefPubMedPubMedCentral
17.
go back to reference Lacroix-Desmazes S, Resnick I, Stahl D, Mouthon L, Espanol T, Levy J, Ochs H. Defective self-reactive antibody repertoire of serum IgM in patients with hyper-IgM syndrome. J Immunol. 1999;162(9):5601–8.PubMed Lacroix-Desmazes S, Resnick I, Stahl D, Mouthon L, Espanol T, Levy J, Ochs H. Defective self-reactive antibody repertoire of serum IgM in patients with hyper-IgM syndrome. J Immunol. 1999;162(9):5601–8.PubMed
18.
go back to reference Moazzami B, Yazdani R, Azizi G, Kiaei F, Tafakori M, Modaresi M, Aghamohammadi A. Respiratory complications in patients with hyper IgM syndrome. J Clin Immunol. 2019;39(6):557–68.CrossRefPubMed Moazzami B, Yazdani R, Azizi G, Kiaei F, Tafakori M, Modaresi M, Aghamohammadi A. Respiratory complications in patients with hyper IgM syndrome. J Clin Immunol. 2019;39(6):557–68.CrossRefPubMed
19.
go back to reference Fazel A, Kashef S, Aleyasin S, Harsini S, Karamizadeh Z, Zoghi S, Rezaei N. Novel AICDA mutation in a case of autosomal recessive hyper-IgM syndrome, growth hormone deficiency and autoimmunity. Allergol Immunopathol. 2017;45(1):82–6.CrossRef Fazel A, Kashef S, Aleyasin S, Harsini S, Karamizadeh Z, Zoghi S, Rezaei N. Novel AICDA mutation in a case of autosomal recessive hyper-IgM syndrome, growth hormone deficiency and autoimmunity. Allergol Immunopathol. 2017;45(1):82–6.CrossRef
20.
go back to reference Picard C, Gaspar HB, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Holland SM. International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol. 2018;38(1):96–128.CrossRefPubMed Picard C, Gaspar HB, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Holland SM. International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol. 2018;38(1):96–128.CrossRefPubMed
21.
go back to reference Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, Davidson NO, Honjo T. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem. 1999;274(26):18470–6.CrossRefPubMed Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, Davidson NO, Honjo T. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem. 1999;274(26):18470–6.CrossRefPubMed
22.
go back to reference Longacre A, Storb U. A novel cytidine deaminase affects antibody diversity. Cell. 2000;102(5):541–4.CrossRefPubMed Longacre A, Storb U. A novel cytidine deaminase affects antibody diversity. Cell. 2000;102(5):541–4.CrossRefPubMed
23.
go back to reference Minegishi Y, Lavoie A, Cunningham-Rundles C, Bédard PM, Hébert J, Côté L, Durandy A. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol. 2000;97(3):203–10.CrossRefPubMed Minegishi Y, Lavoie A, Cunningham-Rundles C, Bédard PM, Hébert J, Côté L, Durandy A. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol. 2000;97(3):203–10.CrossRefPubMed
24.
go back to reference Imai K, Catalan N, Plebani A, Maródi L, Sanal Ö, Kumaki S, Hermine O. Hyper-IgM syndrome type 4 with a B lymphocyte–intrinsic selective deficiency in Ig class-switch recombination. J Clin Investig. 2003;112(1):136–42.CrossRefPubMedPubMedCentral Imai K, Catalan N, Plebani A, Maródi L, Sanal Ö, Kumaki S, Hermine O. Hyper-IgM syndrome type 4 with a B lymphocyte–intrinsic selective deficiency in Ig class-switch recombination. J Clin Investig. 2003;112(1):136–42.CrossRefPubMedPubMedCentral
25.
go back to reference Aghamohammadi A, Parvaneh N, Rezaei N, Moazzami K, Kashef S, Abolhassani H, Hammarström L, et al. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations. J Clin Immunol. 2009;29(6):769.CrossRefPubMed Aghamohammadi A, Parvaneh N, Rezaei N, Moazzami K, Kashef S, Abolhassani H, Hammarström L, et al. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations. J Clin Immunol. 2009;29(6):769.CrossRefPubMed
26.
go back to reference Quartier P, Bustamante J, Sanal O, Plebani A, Debré M, Deville A, Horneff G. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency. Clin Immunol. 2004;110(1):22–9.CrossRefPubMed Quartier P, Bustamante J, Sanal O, Plebani A, Debré M, Deville A, Horneff G. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency. Clin Immunol. 2004;110(1):22–9.CrossRefPubMed
Metadata
Title
Somatic hypermutation defects in two adult hyper immunoglobulin M patients
Authors
Hülya Yilmaz
Sinem Fırtına
Merve Sarıtaş
Müge Sayitoğlu
Muhlis Cem Ar
Publication date
25-07-2022
Publisher
Springer US
Published in
Immunologic Research / Issue 6/2022
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-022-09310-y

Other articles of this Issue 6/2022

Immunologic Research 6/2022 Go to the issue